Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Powis

Showing results (221-230 of 261) with videos related to

Pageof 27
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1988
Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMPK P Windebank, R T Abraham, G Powis, et al.
Biochemical Pharmacology|December 13, 1996
Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73-->Ser mutationJ R Gasdaska, D L Kirkpatrick, W Montfort, et al.
Cell Calcium|September 1, 1990
Transient increases of intracellular Ca2+ induced by volatile anesthetics in rat hepatocytesP A Iaizzo, R A Olsen, M J Seewald, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Reversible inhibition of human thioredoxin reductase activity by cytotoxic alkyl 2-imidazolyl disulfide analoguesJ E Oblong, E L Chantler, A Gallegos, et al.
Toxicology and Applied Pharmacology|March 1, 1989
Potential use of human tissues for toxicity research and testingJ M Frazier, C A Tyson, C McCarthy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suraminG Powis, M J Seewald, D Melder, et al.
Cancer Treatment Reports|March 1, 1986
Disposition of tricyclic nucleoside-5'-monophosphate in blood and plasma of patients during phase I and II clinical trialsG Powis, P J Basseches, D M Kroschel, et al.
Anticancer Research|September 1, 1996
Inhibition of glycosylphosphatidylinositol (GPI) phospholipase D by suramin-like compoundsG Brunner, L Zalkow, E Burgess, et al.
Cancer Research|November 1, 1979
Toxicity and pharmacokinetics of a pyrrolizidine alkaloid, indicine N-oxide, in humansJ S Kovach, M M Ames, G Powis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
D-3-deoxy-3-substituted myo-inositol analogues as inhibitors of cell growthG Powis, I A Aksoy, D C Melder, et al.
Pageof 27

Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1988
Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMPK P Windebank, R T Abraham, G Powis, et al.
Biochemical Pharmacology|December 13, 1996
Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73-->Ser mutationJ R Gasdaska, D L Kirkpatrick, W Montfort, et al.
Cell Calcium|September 1, 1990
Transient increases of intracellular Ca2+ induced by volatile anesthetics in rat hepatocytesP A Iaizzo, R A Olsen, M J Seewald, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Reversible inhibition of human thioredoxin reductase activity by cytotoxic alkyl 2-imidazolyl disulfide analoguesJ E Oblong, E L Chantler, A Gallegos, et al.
Toxicology and Applied Pharmacology|March 1, 1989
Potential use of human tissues for toxicity research and testingJ M Frazier, C A Tyson, C McCarthy, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suraminG Powis, M J Seewald, D Melder, et al.
Cancer Treatment Reports|March 1, 1986
Disposition of tricyclic nucleoside-5'-monophosphate in blood and plasma of patients during phase I and II clinical trialsG Powis, P J Basseches, D M Kroschel, et al.
Anticancer Research|September 1, 1996
Inhibition of glycosylphosphatidylinositol (GPI) phospholipase D by suramin-like compoundsG Brunner, L Zalkow, E Burgess, et al.
Cancer Research|November 1, 1979
Toxicity and pharmacokinetics of a pyrrolizidine alkaloid, indicine N-oxide, in humansJ S Kovach, M M Ames, G Powis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
D-3-deoxy-3-substituted myo-inositol analogues as inhibitors of cell growthG Powis, I A Aksoy, D C Melder, et al.
Pageof 27